Results 191 to 200 of about 612,208 (242)

Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CM313 in Healthy Participants: An Open-Label/Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial. [PDF]

Clin Transl Sci
Yu S, Wu J, Zhao J, He J, Yan H, Zhang X, Yang Y, Song H, Hou Q, Guo B, Qiu Y, Chen B, Xue Y, Zhang J.   +13 more
europepmc   +1 more source

Pharmacokinetics, Safety and Tolerability of Intravenous Lenzilumab, an Anti-GM-CSF Monoclonal Antibody Drug, in Healthy Korean Subjects. [PDF]

Drug Des Devel Ther
Kang J, Bae S, Yu KS, Lee S.
europepmc   +1 more source

The Safety, Tolerability, and Pharmacokinetics of ALT-BB4 (A Novel Recombinant Hyaluronidase): A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study in Healthy Volunteers. [PDF]

Dermatol Ther (Heidelb)
Lee JS, Kim W, Won CH, Lee YW, Lee S, Won H, Park SJ, Lee S, Kim SH, Yang J, Bahn G, Lee DH.   +11 more
europepmc   +1 more source

State of Art of Dose Individualization to Support tacrolimus drug monitoring: What's Next? [PDF]

Transpl Int
Lloberas N, Fernández-Alarcón B, Vidal-Alabró A, Colom H.   +3 more
europepmc   +1 more source

The Effect of α-Mangostin on the Pharmacokinetic Profile of Tofacitinib in Rats Both In Vitro and In Vivo. [PDF]

Biopharm Drug Dispos
Yao J, Lu Z, Zhou Q, Mamun AA, Shi Y, Wang S, Yao Y.   +6 more
europepmc   +1 more source

Chromatography of anticancer drugs [PDF]

, 2013
Cserháti, Tibor, Szőgyi, Mária
core  

A Phase I open-label study to assess the pharmacokinetics, safety, and tolerability of capivasertib alone or in combination with paclitaxel in Chinese patients with advanced solid tumors. [PDF]

BMC Cancer
Zhang J, Liu X, Du Y, Mu Y, Meng Y, Sun Y, Zhang L, Chen C, Cullberg M, Fan E, Hu X.   +10 more
europepmc   +1 more source

Editorial: Diverse functions of drug transporters. [PDF]

Front Pharmacol
Granados JC, Cheung KWK, Prasad B.
europepmc   +1 more source

In vivo assessment of buparvaquone resistant Theileria annulata populations: genetic structure, transmission dynamics, drug susceptibility and pharmacokinetics. [PDF]

PLoS One
Hacilarlioglu S, Bilgic HB, Gokbulut C, Bakirci S, Aksulu A, Shiels B, Tait A, Kose O, Pekagirbas M, Weir W, Aksit D, Karagenc T.   +11 more
europepmc   +1 more source